Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspective.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Virtual Evaluation of Hematoxylin & Eosin via Digital Pathology Survey (VEED) Project: Results from a Non-Inferiority Study of a Tabs-Based Staining Method.

Diagnostics (Basel, Switzerland)·2026
Same author

Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy.

Molecular diagnosis & therapy·2026
Same author

Supernatant: What's in a name?

Cancer cytopathology·2026
Same author

Advances in early-stage lung cancer patients: from preanalytics to molecular analysis.

Critical reviews in oncology/hematology·2026
Same author

Toward Precision Electrochemical Sensing of CFTR Function in Cystic Fibrosis Models.

Analytical chemistry·2026

相关实验视频

Updated: Jun 13, 2025

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

3.9K

固体瘤中的液体活检:一个概述

Pasquale Pisapia1, Antonino Iaccarino2, Giancarlo Troncone1

  • 1Department of Public Health, University of Naples Federico II, Naples, Italy.

Cytopathology : official journal of the British Society for Clinical Cytology
|April 12, 2025
PubMed
概括
此摘要是机器生成的。

使用循环瘤DNA (ctDNA) 的液体活检为癌症分子分析提供了一种非侵入性方法. 这种方法有助于治疗决策,监测最小残留疾病和检测早期癌症.

关键词:
没有NGS,没有NGS.ctDNActDNA是什么意思液体活检活检液体活检分子瘤学分子瘤学分子病理学分子病理学

更多相关视频

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.0K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.8K

相关实验视频

Last Updated: Jun 13, 2025

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

3.9K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.0K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.8K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 遗传学 遗传学 是一个

背景情况:

  • 个性化和精准医学已经改变了癌症护理.
  • 越来越多的生物标志物需要有效的分子分析测试.
  • 液体活检,特别是循环瘤DNA (ctDNA),解决了对非侵入性分子分析的需求.

研究的目的:

  • 审查ctDNA分析在固体瘤中的临床实用性.
  • 突出ctDNA分析相对于传统组织活检的优势.
  • 探索ctDNA在指导癌症治疗和监测中的作用.

主要方法:

  • 对固体瘤中ctDNA分析现有证据的系统审查.
  • 对研究的分析,重点是ctDNA的临床应用.
  • 评估ctDNA在治疗选择,MRD监测和早期检测中的作用.

主要成果:

  • ctDNA分析为组织活检提供了一个非侵入性的替代方案,在样本稀缺时至关重要.
  • 它通过评估对向疗法的反应或抵抗来指导治疗决策.
  • ctDNA有助于监测最小残留疾病 (MRD),并促进癌症的早期检测和拦截.

结论:

  • ctDNA分析是个性化癌症医学中的一个有价值的工具,比基于组织的方法提供了显著的优势.
  • 它在治疗选择,疾病监测和早期癌症检测方面发挥着至关重要的作用.
  • 通过ctDNA分析了解瘤异质性是克服治疗耐药性的关键.